{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:42:35Z","timestamp":1793050955903,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["CA21765"],"award-info":[{"award-number":["CA21765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["R01CA232143-01"],"award-info":[{"award-number":["R01CA232143-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Musicians Against Childhood Cancer"},{"DOI":"10.13039\/100001353","name":"Alexander and Margaret Stewart Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006064","name":"Sontag Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006064","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","award":["NextGen Grant for Transformative Cancer Research"],"award-info":[{"award-number":["NextGen Grant for Transformative Cancer Research"]}],"id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002203","name":"Brain Tumour Charity","doi-asserted-by":"publisher","award":["Quest for Cures"],"award-info":[{"award-number":["Quest for Cures"]}],"id":[{"id":"10.13039\/501100002203","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00401-019-02106-9","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T06:04:18Z","timestamp":1575439458000},"page":"259-271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials"],"prefix":"10.1007","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-9128","authenticated-orcid":false,"given":"Anthony P. Y.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Gudenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent A.","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Paul","family":"Klimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridharan","family":"Gururangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart J.","family":"Kellie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Chintagumpala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Hassall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Indelicato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Onar-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Ellison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Boop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles W.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Northcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Gajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"2106_CR1","doi-asserted-by":"publisher","first-page":"vi203","DOI":"10.1093\/neuonc\/noy148.842","volume":"20","author":"M AbdelBaki","year":"2018","unstructured":"AbdelBaki M, Abu Arja M, Funk Z, Stanek J, Davidson T, Fangusaro J et al (2018) PDCT-13 Pineoblastoma in children: the head start experience. Neuro Oncol 20:vi203\u2013vi203. https:\/\/doi.org\/10.1093\/neuonc\/noy148.842","journal-title":"Neuro Oncol"},{"key":"2106_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DT, Sill M, Hovestadt V, Schrimpf D, Sturm D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469","journal-title":"Nature"},{"key":"2106_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41392-018-0008-7","volume":"3","author":"H Chen","year":"2018","unstructured":"Chen H, Liu H, Qing G (2018) Targeting oncogenic Myc as a strategy for cancer treatment. Sig Transduct Target Ther 3:5. https:\/\/doi.org\/10.1038\/s41392-018-0008-7","journal-title":"Sig Transduct Target Ther"},{"key":"2106_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1215\/15228517-2008-079","volume":"11","author":"M Chintagumpala","year":"2009","unstructured":"Chintagumpala M, Hassall T, Palmer S, Ashley D, Wallace D, Kasow K et al (2009) A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. Neuro Oncol 11:33\u201340. https:\/\/doi.org\/10.1215\/15228517-2008-079","journal-title":"Neuro Oncol"},{"key":"2106_CR5","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1200\/JCO.2010.28.5148","volume":"29","author":"Y-J Cho","year":"2011","unstructured":"Cho Y-J, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H et al (2011) Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol 29:1424\u20131430. https:\/\/doi.org\/10.1200\/JCO.2010.28.5148","journal-title":"J Clin Oncol"},{"key":"2106_CR6","unstructured":"ClinicalTrials.gov (2019) Treatment of patients with newly diagnosed medulloblastoma, supratentorial primitive neuroectodermal tumor, or atypical teratoid rhabdoid tumor. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00085202. Accessed June 10 2019"},{"key":"2106_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-014-1318-7","volume":"128","author":"L de Kock","year":"2014","unstructured":"de Kock L, Sabbaghian N, Druker H, Weber E, Hamel N, Miller S et al (2014) Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol 128:583\u2013595. https:\/\/doi.org\/10.1007\/s00401-014-1318-7","journal-title":"Acta Neuropathol"},{"key":"2106_CR8","doi-asserted-by":"publisher","first-page":"e871","DOI":"10.1016\/j.wneu.2018.07.079","volume":"118","author":"X Deng","year":"2018","unstructured":"Deng X, Yang Z, Zhang X, Lin D, Xu X, Lu X et al (2018) Prognosis of pediatric patients with pineoblastoma: a SEER analysis 1990\u20132013. World Neurosurg 118:e871\u2013e879","journal-title":"World Neurosurg"},{"key":"2106_CR9","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.1200\/jco.2005.01.5479","volume":"23","author":"DW Ellison","year":"2005","unstructured":"Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, Taylor RE et al (2005) beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children\u2019s cancer study group brain tumour committee. J Clin Oncol 23:7951\u20137957. https:\/\/doi.org\/10.1200\/jco.2005.01.5479","journal-title":"J Clin Oncol"},{"key":"2106_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/neuonc\/nos292","volume":"15","author":"C Friedrich","year":"2012","unstructured":"Friedrich C, von Bueren AO, von Hoff K, Gerber NU, Ottensmeier H, Deinlein F et al (2012) Treatment of young children with CNS-primitive neuroectodermal tumors\/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol 15:224\u2013234. https:\/\/doi.org\/10.1093\/neuonc\/nos292","journal-title":"Neuro Oncol"},{"key":"2106_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11060-008-9589-2","volume":"89","author":"SW Gilheeney","year":"2008","unstructured":"Gilheeney SW, Saad A, Chi S, Turner C, Ullrich NJ, Goumnerova L et al (2008) Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy. J Neurooncol 89:89\u201395. https:\/\/doi.org\/10.1007\/s11060-008-9589-2","journal-title":"J Neurooncol"},{"key":"2106_CR12","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1200\/jco.2003.10.096","volume":"21","author":"S Gururangan","year":"2003","unstructured":"Gururangan S, McLaughlin C, Quinn J, Rich J, Reardon D, Halperin EC et al (2003) High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. J Clin Oncol 21:2187\u20132191. https:\/\/doi.org\/10.1200\/jco.2003.10.096","journal-title":"J Clin Oncol"},{"key":"2106_CR13","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1101\/gad.1262504","volume":"18","author":"J Han","year":"2004","unstructured":"Han J, Lee Y, Yeom K-H, Kim Y-K, Jin H, Kim VN (2004) The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18:3016\u20133027. https:\/\/doi.org\/10.1101\/gad.1262504","journal-title":"Genes Dev"},{"key":"2106_CR14","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1200\/jco.2017.76.4720","volume":"36","author":"EI Hwang","year":"2018","unstructured":"Hwang EI, Kool M, Burger PC, Capper D, Chavez L, Brabetz S et al (2018) Extensive molecular and clinical heterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the children\u2019s oncology group randomized ACNS0332 trial. J Clin Oncol 36:3388\u20133395. https:\/\/doi.org\/10.1200\/jco.2017.76.4720","journal-title":"J Clin Oncol"},{"key":"2106_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ccell.2016.02.001","volume":"29","author":"PD Johann","year":"2016","unstructured":"Johann PD, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V et al (2016) Atypical teratoid\/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell 29:379\u2013393. https:\/\/doi.org\/10.1016\/j.ccell.2016.02.001","journal-title":"Cancer Cell"},{"key":"2106_CR16","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1200\/jco.1999.17.6.1829","volume":"17","author":"T Kivela","year":"1999","unstructured":"Kivela T (1999) Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol 17:1829\u20131837. https:\/\/doi.org\/10.1200\/jco.1999.17.6.1829","journal-title":"J Clin Oncol"},{"key":"2106_CR17","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1158\/0008-5472.Can-13-1523","volume":"74","author":"H Koso","year":"2014","unstructured":"Koso H, Tsuhako A, Lyons E, Ward JM, Rust AG, Adams DJ et al (2014) Identification of FoxR2 as an oncogene in medulloblastoma. Cancer Res 74:2351\u20132361. https:\/\/doi.org\/10.1158\/0008-5472.Can-13-1523","journal-title":"Cancer Res"},{"key":"2106_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.celrep.2016.06.004","volume":"16","author":"X Li","year":"2016","unstructured":"Li X, Wang W, Xi Y, Gao M, Tran M, Aziz KE et al (2016) FOXR2 interacts with MYC to promote its transcriptional activities and tumorigenesis. Cell Rep 16:487\u2013497","journal-title":"Cell Rep"},{"key":"2106_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrc3932","volume":"15","author":"S Lin","year":"2015","unstructured":"Lin S, Gregory RI (2015) MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 15:321\u2013333. https:\/\/doi.org\/10.1038\/nrc3932","journal-title":"Nat Rev Cancer"},{"key":"2106_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl) 131:803\u2013820","journal-title":"Acta Neuropathol (Berl)"},{"key":"2106_CR21","doi-asserted-by":"publisher","first-page":"e0205883","DOI":"10.1371\/journal.pone.0205883","volume":"13","author":"JC Mays","year":"2018","unstructured":"Mays JC, Kelly MC, Coon SL, Holtzclaw L, Rath MF, Kelley MW (2018) Single-cell RNA sequencing of the mammalian pineal gland identifies two pinealocyte subtypes and cell type-specific daily patterns of gene expression. PLoS One 13:e0205883. https:\/\/doi.org\/10.1371\/journal.pone.0205883","journal-title":"PLoS One"},{"key":"2106_CR22","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1200\/JCO.2005.00.703","volume":"23","author":"RK Mulhern","year":"2005","unstructured":"Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P et al (2005) Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 23:5511\u20135519","journal-title":"J Clin Oncol"},{"key":"2106_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/neuonc\/now234","volume":"19","author":"M Mynarek","year":"2017","unstructured":"Mynarek M, Pizer B, Dufour C, van Vuurden D, Garami M, Massimino M et al (2017) Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data. Neuro Oncol 19:576\u2013585. https:\/\/doi.org\/10.1093\/neuonc\/now234","journal-title":"Neuro Oncol"},{"key":"2106_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-226434","author":"L Nguyen","year":"2018","unstructured":"Nguyen L, Crawford JR (2018) Pineoblastoma in a child with 22q11.2 deletion syndrome. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2018-226434","journal-title":"BMJ Case Rep"},{"key":"2106_CR25","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1200\/JCO.2009.27.4324","volume":"29","author":"PA Northcott","year":"2011","unstructured":"Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S et al (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29:1408\u20131414. https:\/\/doi.org\/10.1200\/JCO.2009.27.4324","journal-title":"J Clin Oncol"},{"key":"2106_CR26","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.ejca.2006.01.039","volume":"42","author":"BL Pizer","year":"2006","unstructured":"Pizer BL, Weston CL, Robinson KJ, Ellison DW, Ironside J, Saran F et al (2006) Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP\/UKCCSG PNET 3 study. Eur J Cancer 42:1120\u20131128. https:\/\/doi.org\/10.1016\/j.ejca.2006.01.039","journal-title":"Eur J Cancer"},{"key":"2106_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz067","author":"B Poh","year":"2019","unstructured":"Poh B, Koso H, Momota H, Komori T, Suzuki Y, Yoshida N et al (2019) Foxr2 promotes formation of CNS-embryonal tumors in a Trp53-deficient background. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noz067","journal-title":"Neuro Oncol"},{"key":"2106_CR28","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1002\/(sici)1097-0142(20000501)88:9<2189::aid-cncr27>3.0.co;2-g","volume":"88","author":"AT Reddy","year":"2000","unstructured":"Reddy AT, Janss AJ, Phillips PC, Weiss HL, Packer RJ (2000) Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy. Cancer 88:2189\u20132193. https:\/\/doi.org\/10.1002\/(sici)1097-0142(20000501)88:9%3c2189:aid-cncr27%3e3.0.co;2-g","journal-title":"Cancer"},{"key":"2106_CR29","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S1470-2045(18)30204-3","volume":"19","author":"GW Robinson","year":"2018","unstructured":"Robinson GW, Rudneva VA, Buchhalter I, Billups CA, Waszak SM, Smith KS et al (2018) Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. Lancet Oncol 19:768\u2013784","journal-title":"Lancet Oncol"},{"key":"2106_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/jmedgenet-2012-100898","volume":"49","author":"N Sabbaghian","year":"2012","unstructured":"Sabbaghian N, Hamel N, Srivastava A, Albrecht S, Priest JR, Foulkes WD (2012) Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma. J Med Genet 49:417\u2013419","journal-title":"J Med Genet"},{"key":"2106_CR31","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/1097-0142(19930801)72:3<870::AID-CNCR2820720336>3.0.CO;2-X","volume":"72","author":"SE Schild","year":"1993","unstructured":"Schild SE, Scheithauer BW, Schomberg PJ, Hook CC, Kelly PJ, Frick L et al (1993) Pineal parenchymal tumors: clinical, pathologic, and therapeutic aspects. Cancer 72:870\u2013880","journal-title":"Cancer"},{"key":"2106_CR32","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","volume":"24","author":"KAP Schultz","year":"2018","unstructured":"Schultz KAP, Williams GM, Kamihara J, Stewart DR, Harris AK, Bauer AJ et al (2018) DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies. Clin Cancer Res 24:2251\u20132261","journal-title":"Clin Cancer Res"},{"key":"2106_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-019-02020-0","author":"T Sharma","year":"2019","unstructured":"Sharma T, Schwalbe EC, Williamson D, Sill M, Hovestadt V, Mynarek M (2019) Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-019-02020-0","journal-title":"Acta Neuropathol"},{"key":"2106_CR34","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1038\/s41467-018-05029-3","volume":"9","author":"M Snuderl","year":"2018","unstructured":"Snuderl M, Kannan K, Pfaff E, Wang S, Stafford JM, Serrano J et al (2018) Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma. Nat Commun 9:2868. https:\/\/doi.org\/10.1038\/s41467-018-05029-3","journal-title":"Nat Commun"},{"key":"2106_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00401-014-1291-1","volume":"128","author":"T Spence","year":"2014","unstructured":"Spence T, Sin-Chan P, Picard D, Barszczyk M, Hoss K, Lu M et al (2014) CNS-PNETs with C19MC amplification and\/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol (Berl) 128:291\u2013303","journal-title":"Acta Neuropathol (Berl)"},{"key":"2106_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ccr3.880","volume":"5","author":"T Stevens","year":"2017","unstructured":"Stevens T, ten Bosch JVDW, De Rademaeker M, Van Den Bogaert A, van den Akker M (2017) Risk of malignancy in 22q11. 2 deletion syndrome. Clinical Case Rep 5:486","journal-title":"Clinical Case Rep"},{"key":"2106_CR37","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2016.01.015","volume":"164","author":"D Sturm","year":"2016","unstructured":"Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D et al (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2016.01.015","journal-title":"Cell"},{"key":"2106_CR38","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1200\/jco.2005.04.4974","volume":"24","author":"MC Thompson","year":"2006","unstructured":"Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC et al (2006) Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24:1924\u20131931. https:\/\/doi.org\/10.1200\/jco.2005.04.4974","journal-title":"J Clin Oncol"},{"key":"2106_CR39","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ccell.2016.11.003","volume":"30","author":"J Torchia","year":"2016","unstructured":"Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A et al (2016) Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors. Cancer Cell 30:891\u2013908. https:\/\/doi.org\/10.1016\/j.ccell.2016.11.003","journal-title":"Cancer Cell"},{"key":"2106_CR40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"3","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V et al (2003) Coleman CN CTCAE v3. 0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 3:176\u2013181","journal-title":"Semin Radiat Oncol"},{"key":"2106_CR41","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/neuonc\/noz069","volume":"21","author":"SA Upadhyaya","year":"2019","unstructured":"Upadhyaya SA, Robinson GW, Onar-Thomas A, Orr BA, Billups CA, Bowers DC et al (2019) Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial. Neuro Oncol 21:1319\u20131330","journal-title":"Neuro Oncol"},{"key":"2106_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-018-1935-7","volume":"137","author":"E Uro-Coste","year":"2019","unstructured":"Uro-Coste E, Masliah-Planchon J, Siegfried A, Blanluet M, Lambo S, Kool M et al (2019) ETMR-like infantile cerebellar embryonal tumors in the extended morphologic spectrum of DICER1-related tumors. Acta Neuropathol 137:175\u2013177. https:\/\/doi.org\/10.1007\/s00401-018-1935-7","journal-title":"Acta Neuropathol"},{"key":"2106_CR43","doi-asserted-by":"publisher","first-page":"i69","DOI":"10.1093\/neuonc\/noy059.189","volume":"20","author":"S van Rijn","year":"2018","unstructured":"van Rijn S, Vouri M, Pfister SM, Kawauchi D, Kool M (2018) EMBR-04. what the fox say? A molecular analysis of FOXR2 in pediatric brain tumors. Neuro Oncol 20:i69\u2013i69. https:\/\/doi.org\/10.1093\/neuonc\/noy059.189","journal-title":"Neuro Oncol"},{"key":"2106_CR44","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ccell.2015.01.003","volume":"27","author":"AL Walz","year":"2015","unstructured":"Walz AL, Ooms A, Gadd S, Gerhard DS, Smith MA, Guidry Auvil JM et al (2015) Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. Cancer Cell 27:286\u2013297. https:\/\/doi.org\/10.1016\/j.ccell.2015.01.003","journal-title":"Cancer Cell"},{"key":"2106_CR45","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.neuron.2004.08.005","volume":"43","author":"YL Xu","year":"2004","unstructured":"Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH et al (2004) Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43:487\u2013497. https:\/\/doi.org\/10.1016\/j.neuron.2004.08.005","journal-title":"Neuron"}],"updated-by":[{"DOI":"10.1007\/s00401-019-02115-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T00:00:00Z","timestamp":1576886400000}}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02106-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-019-02106-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-02106-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:14:17Z","timestamp":1606954457000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-019-02106-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2106"],"URL":"https:\/\/doi.org\/10.1007\/s00401-019-02106-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00401-019-02115-8","asserted-by":"object"}]},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"assertion":[{"value":"9 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article unfortunately contained a typesetting error in Fig 3c. The corrected Fig. 3 is given in the following page.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}